Roberto Rossotti
0000-0003-4965-8789
5 papers found
Refreshing results…
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort
Safety and efficacy of Daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA Foundation cohorts
Letter: sustained virological response and liver healing
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Missing publications? Search for publications with a matching author name.